Characterisation of oestrogen receptor, progesterone receptor, trefoil factor 1, and epidermal growth factor and its receptor in pancreatic cystic neoplasms and pancreatic ductal adenocarcinoma
- PMID: 12377812
- PMCID: PMC1773438
- DOI: 10.1136/gut.51.5.712
Characterisation of oestrogen receptor, progesterone receptor, trefoil factor 1, and epidermal growth factor and its receptor in pancreatic cystic neoplasms and pancreatic ductal adenocarcinoma
Abstract
Background and aims: The pancreatic cystic neoplasms, including solid pseudopapillary tumour (SPT), mucinous cystic neoplasm (MCN), and intraductal papillary mucin producing tumour (IPMT), have their characteristic clinicopathological features. A systematic investigation of oestrogen receptor (OR), progesterone receptor (PR), trefoil factor 1(TFF1), and epidermal growth factor and its receptor (EGF and EGFR) expressed in pancreatic cystic neoplasms and pancreatic ductal adenocarcinoma was determined to elucidate their corresponding sex and age predilection, cell origin, and pathway of malignant transformation.
Methods: Surgical specimens of SPT (n=10), MCN (n=12), IPMT (n=10), and ductal adenocarcinoma (n=20) were studied. The expression of OR, PR, TFF1, EGF, and EGFR were each determined in each disease entity using monoclonal antibodies by immunohistochemical method. The results were correlated with the clinicopathological data.
Results: PR was expressed in all 10 SPT, whereas OR was expressed in none of 10 SPT. TFF1 was not or weakly expressed in SPT. Although EGF was strongly expressed in seven of 10 SPT, synchronous expression of EGF and its receptor was expressed in none of 10 SPT. Of the 12 MCN, six had PR expression in the stroma cells but not in the neoplastic epithelium, seven had a moderate or strong expression of TFF1, and 10 had no or weak EGFR expression, irrespective of their benigneity or malignancy. Synchronous expression of EGF and EGFR was observed in only one of 12 MCN. Among 10 IPMT, TFF1 and EGFR were moderately or strongly expressed in all six malignancies, whereas TFF1 and EGFR were not or weakly expressed in three of four benigneity. Of 20 ductal adenocarcinomas, TFF1 and EGFR were moderately or strongly expressed in 16 and 12, respectively. Synchronous expression of EGF and EGFR was observed in six of 10 IPMT and nine of 20 ductal adenocarcinoma, respectively.
Conclusion: PR was uniquely expressed in SPT, and OR and PR were expressed in stroma of MCN, reflecting their sex and age predilection. TFF1 expression was related to EGFR such as in IPMT and ductal adenocarcinoma, not related to EGFR such as in MCN, and not related to hormonal receptors such as in SPT. EGF and its receptor might play a part in the malignant transformation of IPMT and ductal adenocarcinoma, but not of SPT and MCN.
Figures


Similar articles
-
Significance of cellular distribution of ezrin in pancreatic cystic neoplasms and ductal adenocarcinoma.Arch Surg. 2005 Dec;140(12):1184-90. doi: 10.1001/archsurg.140.12.1184. Arch Surg. 2005. PMID: 16365240
-
Relation of epidermal growth factor receptor and estrogen receptor-independent pS2 protein to the malignant transformation of mucinous cystic neoplasms of the pancreas.Arch Surg. 1995 Jan;130(1):69-72. doi: 10.1001/archsurg.1995.01430010071014. Arch Surg. 1995. PMID: 7802579
-
Sonic hedgehog signaling pathway in pancreatic cystic neoplasms and ductal adenocarcinoma.Pancreas. 2007 Apr;34(3):340-6. doi: 10.1097/mpa.0b013e3180333ab5. Pancreas. 2007. PMID: 17414057
-
Genomic anomalies in pancreatic tumors other than common adenocarcinoma.Ann N Y Acad Sci. 1999 Jun 30;880:179-90. doi: 10.1111/j.1749-6632.1999.tb09522.x. Ann N Y Acad Sci. 1999. PMID: 10415863 Review.
-
[Anatomy of the head of the pancreas and various limited resection procedures for intraductal papillary-mucinous tumors of the pancreas].Nihon Geka Gakkai Zasshi. 2003 Jun;104(6):460-70. Nihon Geka Gakkai Zasshi. 2003. PMID: 12854493 Review. Japanese.
Cited by
-
Senescence program and its reprogramming in pancreatic premalignancy.Cell Death Dis. 2023 Aug 17;14(8):528. doi: 10.1038/s41419-023-06040-3. Cell Death Dis. 2023. PMID: 37591827 Free PMC article. Review.
-
Management of mucinous cystic neoplasms of the pancreas.World J Gastroenterol. 2010 Dec 7;16(45):5682-92. doi: 10.3748/wjg.v16.i45.5682. World J Gastroenterol. 2010. PMID: 21128317 Free PMC article.
-
Solid serous cystadenoma of the pancreas: a case report of 2 patients revealing vimentin, β-catenin, α-1 antitrypsin, and α-1 antichymotrypsin as new immunohistochemistry staining markers.Medicine (Baltimore). 2015 Mar;94(12):e644. doi: 10.1097/MD.0000000000000644. Medicine (Baltimore). 2015. PMID: 25816032 Free PMC article.
-
Inherited pancreatic cancer.Chin Clin Oncol. 2017 Dec;6(6):58. doi: 10.21037/cco.2017.12.04. Chin Clin Oncol. 2017. PMID: 29307198 Free PMC article. Review.
-
Systems Oncology: Bridging Pancreatic and Castrate Resistant Prostate Cancer.Pathol Oncol Res. 2019 Oct;25(4):1269-1277. doi: 10.1007/s12253-018-0467-8. Epub 2018 Sep 16. Pathol Oncol Res. 2019. PMID: 30220022 Review.
References
-
- Delcore R, Thomas JH, Forster J, et al. Characteristic of cystic neoplasms of the pancreas and results of aggressive surgical treatment. Am J Surg 1992;164:437–42. - PubMed
-
- Compagno J, Oertel JE. Mucinous cystic neoplasms of the pancreas with overt and latent malignancy (cystadenocarcinoma and cystadenoma). Am J Clin Pathol 1978;69:573–80. - PubMed
-
- Itai Y, Ohhashi K, Nagai H, et al. “Ductectatic “ mucinous cystadenoma and cystadenocarcinoma of the pancreas. Radiology 1986;161:697–700. - PubMed
-
- Kloppel G, Solcia E, Longnecker DS, et al. Histological typing of tumors of the exocrine pancreas. In: World Health Organization international histological classification of tumours. 2nd edn. Berlin: Springer, 1996:11–20.
-
- Tenner S, Carr-Locke DL, Banks PA, et al. Intraductal mucin-hypersecreting neoplasm “mucinous ductal ectasia”: endoscopic recognition and management. Am J Gastroenterol 1996;91:2548–54. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous